NUVOX PHARMA, L.L.C. SBIR Phase II Award, April 2023
A SBIR Phase II contract was awarded to NuvOx Pharma in April, 2023 for $301,366.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
301,366
0
Government Branch
Date Awarded
April 15, 2023
0
End Date
March 31, 2026
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1U44NS130589-01
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like NUVOX PHARMA, L.L.C. SBIR Phase II Award, April 2023
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
